COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment
This DCE identified COVID-19 vaccine attributes, such as protection against severe COVID-19, that may influence preference and drive choice and can inform vaccine strategies. The high ranking of common and serious vaccine side effects suggests that, when the efficacy of 2 vaccines is comparable, safety is a key decision-making factor.
Authors
- Nancy M. Waite (ORCID: https://orcid.org/0000-0003-3440-9843)
- David Salisbury (ORCID: https://orcid.org/0009-0005-8926-6570)
- Sumitra Sri Bhashyam (ORCID: https://orcid.org/0000-0001-5815-3518)
- Matthew D. Rousculp (ORCID: https://orcid.org/0009-0001-2509-1098)
- Clara Lehmann (ORCID: https://orcid.org/0000-0002-7042-1578)
- Beth Hahn (ORCID: https://orcid.org/0000-0002-7396-9336)
- Paolo Bonanni (ORCID: https://orcid.org/0000-0003-2875-3744)
- Jeffrey V. Lazarus (ORCID: https://orcid.org/0000-0001-9618-2299)
- Marie de la Cruz (ORCID: https://orcid.org/0000-0002-3343-8960)
Institutions
- Chatham House (GB)
- University of Waterloo (CA)
- City University of New York (US)
- University of Cologne (DE)
- Patient-Centered Outcomes Research Institute (US)
- Novavax (United States) (US)
- Barcelona Institute for Global Health (ES)
- University Hospital Cologne (DE)
- University of Florence (IT)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- JMIR Public Health and Surveillance
- Published
- 2024-10-16
- DOI
- https://doi.org/10.2196/57242
- Citations
- 3
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 1.58